Canaccord Genuity analyst Edward Nash reiterated a Buy rating and $89.00 price target on Apogee Therapeutics Inc (NASDAQ: APGE).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE